Skip to content

Lucid Diagnostics LUCD Extinguishment Of Equity Issuance Costs

Extinguishment Of Equity Issuance Costs at other companies

EVgo, Inc. logo
EVgo, Inc.EVGO
$196.5K
JAC
Jackson Acquisition Company IIJACS
$81.31K
Viking Therapeutics logo
Viking TherapeuticsVKTX
$0-100%
Redwire logo
RedwireRDW
$437.25K
Beneficient logo
BeneficientBENF
$343K-27.6%
PCS
Perceptive Capital SolutionsPCSC
$15.97K

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept lucd:ExtinguishmentOfEquityIssuanceCosts.

The official record: Lucid Diagnostics’s 10-K, filed March 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's extinguishment of equity issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's extinguishment of equity issuance costs?
Lucid Diagnostics (LUCD) reported extinguishment of equity issuance costs of -$269.5K in Q4 2025.
What does extinguishment of equity issuance costs mean?
This metric captures the financial impact of writing off or accelerating the amortization of costs associated with raising equity capital. It typically occurs when equity instruments are retired or when specific financing arrangements are terminated prematurely. Tracking this item helps investors isolate non-recurring financing charges from core operational performance.